The Recall Desk
Agency classClass IIOur severity:SevereFDA (Drugs)·D-0346-2016·Announced 2015-11-25

Downing Labs Recalls Co-Enzyme Q-10 Injectable Due to Sterility Concerns

Downing Labs, LLC is recalling Co-Enzyme Q-10 Injectable vials because the product lacks assurance of sterility. The recall covers all lots distributed in the US and internationally.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls involving significant injury reports or structural defects are rated Severe; while no injuries are explicitly reported here, the lack of sterility assurance in an injectable drug represents a significant risk of harm that aligns with the Severe classification for Class II drug recalls.

Plain-English summary

Downing Labs, LLC is voluntarily recalling Co-Enzyme Q-10 Injectable, 20mg/mL, 10mL vials. The recall is being conducted because the product lacks assurance of sterility. The affected product is prescription-only and was distributed nationwide in the United States as well as in Australia, Brazil, the Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, the Philippines, Singapore, Thailand, Trinidad and Tobago, and Taiwan.

The recall includes all lots of the product. The source text does not specify the number of units affected or report any specific illnesses or injuries associated with the use of the recalled vials.

Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider for further instructions. Downing Labs, LLC can be reached at 1-800-914-7435 for additional information regarding the recall.

The recalled product

Product
Co-Enzyme Q-10 Injectable, 20mg/mL, 10mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435
Manufacturer
Downing Labs, LLC
Category
Drug — Injectable
Hazard
Affected units
12

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 48 recalled by Downing Labs, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 48 products in this recall →

Related recalls

Same manufacturer · Downing Labs, LLC

See all →

Same hazard · sterility

See all →

Similar recalls